Showing results (11-20 of 15) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal for Immunotherapy of Cancer|August 6, 2024
Randomized, open-label, phase 2 study of nivolumab plus ipilimumab or nivolumab monotherapy in patients with advanced or metastatic solid tumors of high tumor mutational burdenMichael Schenker, Mauricio Burotto, Martin Richardet, et al.JCO Precision Oncology|January 14, 2026
Generic Protocols for Analytical Validation of Tumor-Informed Circulating Tumor DNA Assays for Molecular Residual Disease: The Blood Profiling Atlas in Cancer's Molecular Residual Disease Analytical Validation Working Group Consensus RecommendationJonathan Baden, Cheng-Ho Jimmy Lin, Andrew T Anfora, et al.Journal for Immunotherapy of Cancer|March 29, 2020
Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization ProjectDiana M Merino, Lisa M McShane, David Fabrizio, et al.The Journal of Molecular Diagnostics : JMD|February 24, 2023
Contrived Materials and a Data Set for the Evaluation of Liquid Biopsy Tests: A Blood Profiling Atlas in Cancer (BLOODPAC) Community StudyKyle M Hernandez, Kelli S Bramlett, Phaedra Agius, et al.JCO Precision Oncology|August 11, 2022
Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non-Small-Cell Lung Cancer Treated With Immune Checkpoint InhibitorsDiana Merino Vega, Katherine K Nishimura, Névine Zariffa, et al.Pageof 2